These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15518139)

  • 1. [Pathologic-anatomic diagnosis of endocrine neoplasms: new trends and applications].
    Kaserer K
    Wien Klin Wochenschr; 2003; 115 Suppl 2():6-9. PubMed ID: 15518139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [WHO Classification of digestive tumors: the fourth edition].
    Fléjou JF
    Ann Pathol; 2011 Nov; 31(5 Suppl):S27-31. PubMed ID: 22054452
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating markers for endocrine tumours of the gastroenteropancreatic tract.
    Ardill JE
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):539-59. PubMed ID: 18941127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative genomic hybridization (CGH): application to the study of neuroendocrine tumors].
    Terris B; Bernheim A
    Ann Pathol; 1999; 19(5 Suppl):S9-11. PubMed ID: 10599452
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour biology and histopathology of neuroendocrine tumours.
    Klöppel G
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
    de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
    Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathologic diagnostic for a primary of metastatic neuroendocrine tumor].
    Leteurtre E
    Ann Pathol; 2011 Nov; 31(5 Suppl):S79-80. PubMed ID: 22054469
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.
    Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future diagnostic and therapeutic trends in endocrine cancers.
    Spiegel AM; Libutti SK
    Semin Oncol; 2010 Dec; 37(6):691-5. PubMed ID: 21167386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiles of gastroenteropancreatic endocrine tumors.
    Perren A; Anlauf M; Komminoth P
    Virchows Arch; 2007 Aug; 451 Suppl 1():S39-46. PubMed ID: 17684763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ki67 and neuroendocrine tumors].
    Couvelard A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S55-6. PubMed ID: 22054461
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary neuroendocrine tumors of the gastroenteropancreatic system.
    Anlauf M; Garbrecht N; Bauersfeld J; Schmitt A; Henopp T; Komminoth P; Heitz PU; Perren A; Klöppel G
    Virchows Arch; 2007 Aug; 451 Suppl 1():S29-38. PubMed ID: 17684762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; McMillan A
    Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.